DLL4 is an activator protein of the non-canonical Notch signaling pathway.DLL4 antibody was confirmed to be effective against both KRAS wild-type and mutant CRC cells, effectively eradicating CR-CSCs and enhancing the antitumor effect of irinotecan [114,137]. This evidence concerns the gene KRAS and colorectal carcinoma.